#Japan #Johnson & Johnson #Tokyo #Lung Cancer #Value of Time

Johnson & Johnson’s Commitment to Lung Cancer Awareness

On August 1, recognized globally as World Lung Cancer Day, Johnson & Johnson (J&J) launched its 'Value of Time' campaign aimed at lung cancer patients and their families. This initiative is designed to instill a sense of hope that every second spent with loved ones can enhance their quality of life, even amidst the challenges of cancer treatment.

The campaign emphasizes the intrinsic value of time for patients diagnosed with lung cancer. Research conducted within Japan highlights that for these individuals, extending their lifespan remains a top priority. The findings suggest that the value placed on time is significantly heightened after a lung cancer diagnosis, making every moment shared with family and friends crucial for their emotional and mental well-being.

Further supporting this perspective, studies indicate that hope can serve as a powerful motivator for lung cancer patients. Research conducted on patients' daily experiences reveals that those who find hope in various aspects of life are more likely to engage in social activities and exhibit improved physical function. This leads to a richer, fuller life, characterized by precious moments spent in the company of family, pursuing hobbies, and appreciating the beauty of life's simple pleasures.

J&J recognizes the need to assist lung cancer patients in their journey. Through the 'Value of Time' campaign, the company aims to develop a range of resources, initially featuring a dedicated website that delivers valuable content and support. This includes videos that visualize the importance of each moment, tools to enhance communication between patients and healthcare providers, and shared decision-making (SDM) tools that aim to empower patients in understanding and selecting their treatment options.

As part of their commitment to this cause, J&J understands that shared decision-making is crucial in the treatment process. Patients are encouraged to express their thoughts and preferences to their physicians, ensuring they receive care that aligns with their personal values and needs. By empowering patients through information and support, J&J hopes to foster an environment where every patient feels supported and valued.

J&J also plans to release various multimedia content supporting this campaign, involving interviews and reports demonstrating real patient experiences with hope and resilience.

The campaign is not only a local initiative but part of a larger global effort by J&J to address lung cancer treatment. With the rising trend of personalized and precision medicine in oncology, J&J aims to contribute significantly to patient care through innovative therapies while ensuring that patients do not navigate their cancer journey alone.

Furthermore, J&J is dedicated to enhancing their role as a leading company in lung cancer treatment. They commit to providing substantial information related to SDM, not only domestic but also internationally, to elevate the overall healthcare experience and keep the well-being of patients at the forefront.

In cultivating hope and support for lung cancer patients, J&J invites everyone to join the 'Value of Time' campaign. This initiative is a testament to the belief that time—every precious second—should be valued, especially in the fight against lung cancer.

To dive deeper into the campaign and explore various resources, visit the dedicated campaign website at Value of Time. J&J remains committed to driving innovation in medicine while shaping a future that not only treats disease but also acknowledges the fundamental human experience behind each diagnosis.

For more information on Johnson & Johnson's Innovative Medicine in Japan and their ongoing projects, please visit J&J Innovative Medicine Japan.